Daron Evans bought $29k of RZLT
CFO at Rezolute, Inc.. 10,000 shares at an average of $2.85, traded Mar 30, 2026, filed Mar 31, 2026.
Score components
- +22RoleCFO
- +5Trade size$28k at market
- 0Relative to holdingsHoldings up 2.5%
- +8Price context74% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +4.9%, 3m +70.5%, 6m +34.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000912282-26-000533, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 30, 2026 | POpen-market purchase Common Shares | +10,000 | $2.85 | $29k | 414,462 | Mar 31, 2026 |
Related signals
Other insiders at Rezolute, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | Rezolute, Inc. | Wladimir Hogenhuis director | $9,549 5,650 shares | +5% | |
| 48Moderate | Rezolute, Inc. | Brian Kenneth Roberts Chief Medical Officer | $48k 28,000 shares | +10% | |
| 58Moderate | Rezolute, Inc. | Nevan C Elam CEO | $51k 32,000 shares | +5% | |
| 62Notable | Rezolute, Inc. | Daron Evans CFO | $80k 45,000 shares | +12% | |
| 44Moderate | Rezolute, Inc. | Sunil Ratilal Karnawat Chief Commercial Officer | $20k 12,100 shares | +20% | |
| 37Weak | Rezolute, Inc. | Brian Kenneth Roberts Chief Medical Officer | $11k 2,500 shares | +19% | |
| 46Moderate | Rezolute, Inc. | Daron Evans CFO | $20k 5,000 shares | +2% | |
| 37Weak | Rezolute, Inc. | Nerissa Kreher director | $9,997 3,076 shares | +9% | |
| 62Notable | Rezolute, Inc. | Young-Jin Kim director | $4.0M 1,230,769 shares | +17% | |
| 56Moderate | Rezolute, Inc. | Wladimir Hogenhuis director | $20k 6,758 shares | +9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.